Milestone Pharmaceuticals (MIST) Retained Earnings: 2021

Historic Retained Earnings for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to -$208.0 million.

  • Milestone Pharmaceuticals' Retained Earnings fell 32.78% to -$251.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$251.5 million, marking a year-over-year decrease of 32.78%. This contributed to the annual value of -$208.0 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, Milestone Pharmaceuticals' Retained Earnings is -$208.0 million.
  • Milestone Pharmaceuticals' 5-year Retained Earnings high stood at -$208.0 million for FY2021, and its period low was -$208.0 million during FY2021.
  • For the 1-year period, Milestone Pharmaceuticals' Retained Earnings averaged around -$208.0 million, with its median value being -$208.0 million (2021).